May 16, 2019
|
May 20, 2019
|
March 3, 2021
|
October 15, 2019
|
July 2023 (Final data collection date for primary outcome measure)
|
- Change in patient´s function from baseline to 12 months [ Time Frame: 12 months ]
Clinical outcome in function as measured by the 100 point Oswestry Disability Index (ODI). Zero is equated with no disability and 100 is the maximum disability possible.
- The rate of cage migration in cage-plus-screw systems. [ Time Frame: 12 months and 24 months post operatively ]
Defined as posterior movement of the cage past the posterior wall of the vertebral body.
- The rate of pedicle screw loosening in screw only and cage-plus-screw systems. [ Time Frame: 12 months and 24 months post operatively ]
A radiolucent zone, >1mm, surrounding the pedicle screw seen in radiograhs
|
- To evaluate the efficacy (performance) of the Neo Pedicle Screw System™ and the Neo Cage system™. [ Time Frame: 24 months post operative ]
To demonstrate non-inferiority of function as measured by the 100-point Oswestry Disability Index (ODI) to an historical control from the published medical literature on competitive devices.
- To evaluate the safety of the Neo Pedicle Screw System™ and the Neo Cage system™. [ Time Frame: 24 months post operative ]
For safety, the rate of pedicle screw loosening and cage migration will be compared to published results of other state-of-the-art stabilization systems.
|
|
Not Provided
|
Not Provided
|
Not Provided
|
Not Provided
|
|
PMCF Neo Pedicle Screw and Cage Systems
|
Fusion With the Neo Pedicle Screw and Cage Systems: A Post Market Clinical Follow-up Study
|
The objectives of this clinical observational study is to evaluate the safety and efficacy (performance) of the Neo Pedicle Screw System™ and the Neo Cage System™ interbody fusion device. To demonstrate non-inferiority of safety and function to an historical control from the published medical literature on competitive devices.
|
Not Provided
|
Observational
|
Observational Model: Cohort Time Perspective: Other
|
Not Provided
|
Not Provided
|
Non-Probability Sample
|
In total, approximately 150 patients will be recruited and enrolled to ensure that at least 132 patients are evaluable at 12 and 24 months. Patients are recruited consecutively, retrospectively as well as prospectively. The potential patients to be recruited have either already been implanted or are planned to be implanted with the Neo Pedicle Screw System (Arm 1) or Neo Cage System and Neo Pedicle Screw System (Arm 2).
|
- Degenerative Disc Disease
- Spondylolisthesis
- Spinal Stenosis
- Spinal Tumor
- Trauma
- Pseudoarthrosis of Spine
|
- Device: NEO Pedicle Screw System™
The NEO Pedicle Screw System™ is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion.
- Device: Neo Cage System™
Neo Cage System™ is intended to be used with bone graft material to facilitate interbody fusion and to be used with the NEO Pedicle Screw System™
|
|
Not Provided
|
|
Recruiting
|
150
|
Same as current
|
July 2023
|
July 2023 (Final data collection date for primary outcome measure)
|
Inclusion criteria:
- Patient has undergone or is intended to undergo surgery with the Neo Pedicle Screw System™, standalone or in combination with the Neo Cage System™, for any of the approved indications as defined in the respective labelling
- Patient has participated in or is willing to participate in the routine postoperative follow-up program
- Patient is willing to provide written informed consent
Exclusion criteria:
- Patient is under the age of 18 or skeletally immature
- Patient had or has a contraindication to surgery or to any of the implant systems used in the study, as defined in the respective labelling
|
Sexes Eligible for Study: |
All |
|
18 Years and older (Adult, Older Adult)
|
No
|
Contact: ingrid Moberg, DDS |
+46 725 45 35 29 |
ingrid.moberg@neo-medical.com |
|
|
Germany, Spain
|
|
|
NCT03956537
|
NeoPMCF01
|
Not Provided
|
Not Provided
|
Not Provided
|
Neo Medical SA
|
Neo Medical SA
|
ConfinisCPM
|
Principal Investigator: |
David C Noriega, PhD, MD |
Spine Center, University Hospital Valladolid, Valladolid, Spain |
Principal Investigator: |
Yasser Abdalla, MD |
Dep. of Neurosurgery, Nordwest Krankenhaus Sanderbusch, Sande, Germany |
|
Neo Medical SA
|
March 2021
|